Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Appropriate use of interferon beta-1a in multiple sclerosis.

Jacobs L, Brownscheidle CM.

BioDrugs. 1999 Mar;11(3):155-63.

PMID:
18031126
2.

Pattern reversal visual evoked potentials as a measure of visual pathway pathology in multiple sclerosis.

Weinstock-Guttman B, Baier M, Stockton R, Weinstock A, Justinger T, Munschauer F, Brownscheidle C, Williams J, Fisher E, Miller D, Rudick R.

Mult Scler. 2003 Oct;9(5):529-34. Review.

PMID:
14582782
3.
4.

Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium.

Weinstock-Guttman B, Jacobs LD, Brownscheidle CM, Baier M, Rea DF, Apatoff BR, Blitz KM, Coyle PK, Frontera AT, Goodman AD, Gottesman MH, Herbert J, Holub R, Lava NS, Lenihan M, Lusins J, Mihai C, Miller AE, Perel AB, Snyder DH, Bakshi R, Granger CV, Greenberg SJ, Jubelt B, Krupp L, Munschauer FE, Rubin D, Schwid S, Smiroldo J; New York State Multiple Sclerosis Consortium.

Mult Scler. 2003 Jun;9(3):293-8.

PMID:
12814178
5.

Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients.

Nguyen LT, Ramanathan M, Weinstock-Guttman B, Baier M, Brownscheidle C, Jacobs LD.

J Neurol Sci. 2003 May 15;209(1-2):93-9.

PMID:
12686409
6.

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997.

Rudick RA, Goodkin DE, Jacobs LD, Cookfair DL, Herndon RM, Richert JR, Salazar AM, Fischer JS, Granger CV, Simon JH, Alam JJ, Simonian NA, Campion MK, Bartoszak DM, Bourdette DN, Braiman J, Brownscheidle CM, Coats ME, Cohan SL, Dougherty DS, Kinkel RP, Mass MK, Munschauer FE, Priore RL, Pullicino PM, Scherokman BJ, Weistock-Guttman B, Whitham RH; Multiple Sclerosis Collaborative Research Group.

Neurology. 2001 Dec;57(12 Suppl 5):S25-30. No abstract available.

PMID:
11902591
7.

In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects.

Ramanathan M, Weinstock-Guttman B, Nguyen LT, Badgett D, Miller C, Patrick K, Brownscheidle C, Jacobs L.

J Neuroimmunol. 2001 Jun 1;116(2):213-9.

PMID:
11438176
8.

Are quantitative functional measures more sensitive to worsening MS than traditional measures?

Schwid SR, Goodman AD, Apatoff BR, Coyle PK, Jacobs LD, Krupp LB, Miller AE, Wende KE, Brownscheidle CM, New York State Multiple Sclero.

Neurology. 2000 Dec 26;55(12):1901-3.

PMID:
11134392
9.

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, Simonian NA, Slasor PJ, Sandrock AW.

N Engl J Med. 2000 Sep 28;343(13):898-904.

10.

Detection of cytochrome P450 and other drug-metabolizing enzyme mRNAs in peripheral blood mononuclear cells using DNA arrays.

Nguyen LT, Ramanathan M, Weinstock-Guttman B, Dole K, Miller C, Planter M, Patrick K, Brownscheidle C, Jacobs LD.

Drug Metab Dispos. 2000 Aug;28(8):987-93.

PMID:
10901711
11.

The evaluation of the health care needs of women with disabilities.

Weppner DM, Brownscheidle CM.

Prim Care Update Ob Gyns. 1998 Jul 1;5(4):210.

PMID:
10838397
12.

A profile of multiple sclerosis: the New York State Multiple Sclerosis Consortium.

Jacobs LD, Wende KE, Brownscheidle CM, Apatoff B, Coyle PK, Goodman A, Gottesman MH, Granger CV, Greenberg SJ, Herbert J, Krupp L, Lava NS, Mihai C, Miller AE, Perel A, Smith CR, Snyder DH.

Mult Scler. 1999 Oct;5(5):369-76.

PMID:
10516782
13.

A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

Simon JH, Jacobs LD, Campion MK, Rudick RA, Cookfair DL, Herndon RM, Richert JR, Salazar AM, Fischer JS, Goodkin DE, Simonian N, Lajaunie M, Miller DE, Wende K, Martens-Davidson A, Kinkel RP, Munschauer FE 3rd, Brownscheidle CM.

Neurology. 1999 Jul 13;53(1):139-48.

PMID:
10408550
14.

Flow cytometric analysis of in vitro proinflammatory cytokine secretion in peripheral blood from multiple sclerosis patients.

Nguyen LT, Ramanathan M, Munschauer F, Brownscheidle C, Krantz S, Umhauer M, Miller C, DeNardin E, Jacobs LD.

J Clin Immunol. 1999 May;19(3):179-85.

PMID:
10404403
15.

Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

Rudick RA, Cookfair DL, Simonian NA, Ransohoff RM, Richert JR, Jacobs LD, Herndon RM, Salazar AM, Fischer JS, Granger CV, Goodkin DE, Simon JH, Bartoszak DM, Bourdette DN, Braiman J, Brownscheidle CM, Coats ME, Cohan SL, Dougherty DS, Kinkel RP, Mass MK, Munchsauer FE, O'Reilly K, Priore RL, Whitham RH, et al.

J Neuroimmunol. 1999 Jan 1;93(1-2):8-14.

PMID:
10378864
16.

Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials. The Multiple Sclerosis Collaborative Research Group (MSCRG).

Goodkin DE, Priore RL, Wende KE, Campion M, Bourdette DN, Herndon RM, Fischer JS, Jacobs LD, Cookfair DL, Rudick RA, Richert JR, Salazar AM, Granger CV, Simon JH, Alam JJ, Bartoszak DM, Braiman J, Brownscheidle CM, Coats ME, Cohan SL, Dougherty DS, Kinkel RP, Mass MK, Munschauer FE 3rd, Whitham RH, et al.

Mult Scler. 1998 Dec;4(6):480-6.

PMID:
9987756
17.

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

Simon JH, Jacobs LD, Campion M, Wende K, Simonian N, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM, Alam JJ, Fischer JS, Goodkin DE, Granger CV, Lajaunie M, Martens-Davidson AL, Meyer M, Sheeder J, Choi K, Scherzinger AL, Bartoszak DM, Bourdette DN, Braiman J, Brownscheidle CM, Whitham RH, et al.

Ann Neurol. 1998 Jan;43(1):79-87.

PMID:
9450771
18.

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

Rudick RA, Goodkin DE, Jacobs LD, Cookfair DL, Herndon RM, Richert JR, Salazar AM, Fischer JS, Granger CV, Simon JH, Alam JJ, Simonian NA, Campion MK, Bartoszak DM, Bourdette DN, Braiman J, Brownscheidle CM, Coats ME, Cohan SL, Dougherty DS, Kinkel RP, Mass MK, Munschauer FE, Priore RL, Whitham RH, et al.

Neurology. 1997 Aug;49(2):358-63.

PMID:
9270562
19.

Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis.

Jacobs LD, Kaba SE, Miller CM, Priore RL, Brownscheidle CM.

Ann Neurol. 1997 Mar;41(3):392-8.

PMID:
9066361
20.

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM, Fischer JS, Goodkin DE, Granger CV, Simon JH, Alam JJ, Bartoszak DM, Bourdette DN, Braiman J, Brownscheidle CM, Coats ME, Cohan SL, Dougherty DS, Kinkel RP, Mass MK, Munschauer FE 3rd, Priore RL, Pullicino PM, Scherokman BJ, Whitham RH, et al.

Ann Neurol. 1996 Mar;39(3):285-94. Erratum in: Ann Neurol 1996 Sep;40(3):480.

PMID:
8602746
21.

Outcome measurement in medical rehabilitation.

Granger CV, Brownscheidle CM.

Int J Technol Assess Health Care. 1995 Spring;11(2):262-8.

PMID:
7790169
22.

Absent or delayed preovulatory luteinizing hormone surge in experimental diabetes mellitus.

Katayama S, Brownscheidle CM, Wootten V, Lee JB, Shimaoka K.

Diabetes. 1984 Apr;33(4):324-7.

PMID:
6368291
23.

The effects of maternal diabetes on fetal maturation and neonatal health.

Brownscheidle CM, Wootten V, Mathieu MH, Davis DL, Hofmann IA.

Metabolism. 1983 Jul;32(7 Suppl 1):148-55.

PMID:
6865765
24.

Orally administered liposome-entrapped insulin in diabetic animals. A critical assessment.

Arrieta-Molero JF, Aleck K, Sinha MK, Brownscheidle CM, Shapiro LJ, Sperling MA.

Horm Res. 1982 Jul-Aug;16(4):249-56.

PMID:
6751980
25.

Localization of aldose reductase and sorbitol dehydrogenase in the nervous system of normal and diabetic rats.

Orosz SE, Townsend SF, Tornheim PA, Brownscheidle CM.

Acta Diabetol Lat. 1981 Oct-Dec;18(4):373-81.

PMID:
6800175
26.
27.

Ultrastructure of the harderian gland in male albino rats.

Brownscheidle CM, Niewenhuis RJ.

Anat Rec. 1978 Mar;190(3):735-53.

PMID:
637321

Supplemental Content

Loading ...
Support Center